Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis

To assess the safety and efficacy of the StarClose device following peripheral vascular interventions employing 7-F and 8-F femoral sheaths. From May 2006 to December 2007, 226 consecutive patients (143 men; mean age 69 years, range 36-92) underwent 231 groin punctures (150 with a 7-F sheath and 81...

Full description

Saved in:
Bibliographic Details
Published in:Journal of endovascular therapy 2009-08, Vol.16 (4), p.475-482
Main Authors: Branzan, Daniela, Sixt, Sebastian, Rastan, Aljoscha, Schwarz, Thomas, Schwarzwälder, Uwe, Bürgelin, Karlheinz, Noory, Elias, Beyersdorf, Friedhelm, Zeller, Thomas
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Aneurysm, False - etiology
Arterial Occlusive Diseases - etiology
Arteriovenous Fistula - etiology
Catheterization, Peripheral - adverse effects
Catheterization, Peripheral - instrumentation
Constriction, Pathologic
Dissection
Equipment Design
Feasibility Studies
Female
Femoral Artery
Hematoma - etiology
Hemorrhage - etiology
Hemorrhage - prevention & control
Hemostatic Techniques - adverse effects
Hemostatic Techniques - instrumentation
Humans
Male
Medical imaging
Men
Middle Aged
Patients
Physical examinations
Pressure
Punctures
Retrospective Studies
Standard deviation
Success
Thrombosis
Treatment Outcome
Vascular Diseases - etiology
Vascular Diseases - therapy
Veins & arteries
Venous Thrombosis - etiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To assess the safety and efficacy of the StarClose device following peripheral vascular interventions employing 7-F and 8-F femoral sheaths. From May 2006 to December 2007, 226 consecutive patients (143 men; mean age 69 years, range 36-92) underwent 231 groin punctures (150 with a 7-F sheath and 81 with an 8-F sheath) that were sealed with the StarClose Vascular Closure System. All the patients underwent duplex control of the puncture site 24 hours after deployment of the device to determine the presence of vascular complications (hematoma, pseudoaneurysm, arteriovenous fistula, and arterial/venous thrombosis or stenosis). Endpoints were major vascular complications during the hospital stay, device success (hemostasis using the StarClose device alone or with
ISSN:1526-6028
1545-1550
DOI:10.1583/09-2761R.1